Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,219Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Aurobindo Pharma Limited

02 1Cipla Ltd.

03 1Curia Spain S.A.U.

04 1Erregierre SpA

05 1Hetero Drugs Limited

06 1MSN Laboratories Private Limited

07 1MYLAN LABORATORIES LIMITED

08 1Piramal Pharma Limited

09 1Unichem Laboratories Limited, India

10 1Viyash Life Sciences Private Limited

11 1Zydus Lifesciences Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AACR Annual meeting
Not Confirmed
arrow

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PRAMIPEXOLE DIHYDROCHLORIDE

NDC Package Code : 53104-7589

Start Marketing Date : 2016-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

03

AACR Annual meeting
Not Confirmed
arrow

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PRAMIPEXOLE DIHYDROCHLORIDE

NDC Package Code : 49706-1868

Start Marketing Date : 2010-07-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PRAMIPEXOLE DIHYDROCHLORIDE

NDC Package Code : 65977-0021

Start Marketing Date : 1997-07-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

AACR Annual meeting
Not Confirmed
arrow

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PRAMIPEXOLE DIHYDROCHLORIDE

NDC Package Code : 65085-0056

Start Marketing Date : 2016-05-18

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (5kg/5kg)

Marketing Category : BULK INGREDIENT

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PRAMIPEXOLE DIHYDROCHLORIDE

NDC Package Code : 53747-038

Start Marketing Date : 2012-03-31

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PRAMIPEXOLE DIHYDROCHLORIDE

NDC Package Code : 65015-768

Start Marketing Date : 2015-02-19

End Marketing Date : 2026-12-01

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PRAMIPEXOLE DIHYDROCHLORIDE

NDC Package Code : 65841-153

Start Marketing Date : 2018-01-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

Looking for 191217-81-9 / Pramipexole API manufacturers, exporters & distributors?

Pramipexole manufacturers, exporters & distributors 1

51

PharmaCompass offers a list of Pramipexole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pramipexole manufacturer or Pramipexole supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pramipexole manufacturer or Pramipexole supplier.

PharmaCompass also assists you with knowing the Pramipexole API Price utilized in the formulation of products. Pramipexole API Price is not always fixed or binding as the Pramipexole Price is obtained through a variety of data sources. The Pramipexole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Pramipexole

Synonyms

191217-81-9, Mirapex, (s)-n6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride hydrate, Pramipexole 2hcl monohydrate, Pramipexole hydrochloride, Sifrol

Cas Number

191217-81-9

Unique Ingredient Identifier (UNII)

3D867NP06J

About Pramipexole

A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME.

Mirapex Manufacturers

A Mirapex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mirapex, including repackagers and relabelers. The FDA regulates Mirapex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mirapex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Mirapex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Mirapex Suppliers

A Mirapex supplier is an individual or a company that provides Mirapex active pharmaceutical ingredient (API) or Mirapex finished formulations upon request. The Mirapex suppliers may include Mirapex API manufacturers, exporters, distributors and traders.

click here to find a list of Mirapex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Mirapex NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mirapex as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Mirapex API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Mirapex as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Mirapex and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mirapex NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Mirapex suppliers with NDC on PharmaCompass.

Mirapex Manufacturers | Traders | Suppliers

Mirapex Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.